Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: A randomised clinical trial

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 5, 2014, Pages 385-395

  Kwakernaak, Arjan J ^a   Krikken, Jan A ^a   Binnenmars, S Heleen ^b   Visser, Folkert W ^a   Hemmelder, Marc H ^c   Woittiez, Arend Jan ^b   Groen, Henk ^a   Laverman, Gozewijn D ^a,b   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Internal Medicine   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLOROTHIAZIDE; LISINOPRIL; PLACEBO; SODIUM; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT;

ADULT; ALBUMINURIA; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SODIUM RESTRICTION; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; AGED; CROSSOVER PROCEDURE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; SODIUM INTAKE; BLOOD PRESSURE; CLINICAL TRIAL; DIABETIC NEUROPATHIES; DIET THERAPY; DRUG EFFECTS; MIDDLE AGED;

AGED; ALBUMINURIA; BLOOD PRESSURE; DIABETIC NEUROPATHIES; DIET, SODIUM-RESTRICTED; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM;

EID: 84899980423     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70030-0     Document Type: Article

References (31)

1. Parving H-H, Østerby R, Ritz E Diabetic nephropathy. The Kidney 2000, 1731-1773. WB Saunders, Philadephia. B.M. Brenner (Ed.).
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444.
3. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345:870-878.
4. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008, 19:999-1007.
5. Slagman MC, Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ 2011, 343:d4366.
6. Ekinci EI, Thomas G, Thomas D, et al. Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake. Diabetes Care 2009, 32:1398-1403.
7. Lambers Heerspink HJ, Holtkamp FA, Parving HH, et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 2012, 82:330-337.
8. Krikken JA, Lely AT, Bakker SJ, Navis G The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 2007, 71:260-265.
9. Correa JA, Bellavance F Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials. Stat Med 2001, 20:1185-1196.
10. Zhou J, Yuan Y, Reynolds R, Raber S, Li Y Cost-efficient higher-order crossover designs in comparative bioavailability studies. Clin Pharmacokinet 2006, 45:623-632.
11. Guideline on sodium intake for adults and children WHO, (accessed Aug 16, 2013). http://www.who.int/nutrition/publications/guidelines.
12. Swift PA, Markandu ND, Sagnella GA, He FJ, Macgregor GA Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005, 46:308-312.
13. He FJ, Marciniak M, Visagie E, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009, 54:482-488.
14. Houlihan CA, Allen TJ, Baxter AL, et al. A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 2002, 25:663-671.
15. Vedovato M, Lepore G, Coracina A, et al. Effect of sodium intake on blood pressure and albuminuria in type 2 diabetic patients: the role of insulin resistance. Diabetologia 2004, 47:300-303.
16. Muhlhauser I, Prange K, Sawicki PT, et al. Effects of dietary sodium on blood pressure in IDDM patients with nephropathy. Diabetologia 1996, 39:212-219.
17. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013, 3:1-150. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.
18. Suckling RJ, He FJ, Macgregor GA Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev 2010, 12. CD006763.
19. Navis G, de Jong P, Donker AJ, van der Hem GK, de Zeeuw D Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients. J Cardiovasc Pharmacol 1987, 9:743-748.
20. Imanishi M, Yoshioka K, Okumura M, et al. Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients. Diabetes Care 2001, 24:111-116.
21. Trevisan R, Bruttomesso D, Vedovato M, et al. Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes 1998, 47:1347-1353.
22. Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, Taylor KG Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 1989, 298:227-230.
23. Petrie JR, Morris AD, Minamisawa K, et al. Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83:1552-1557.
24. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 2012, 23:165-173.
25. Ekinci EI, Clarke S, Thomas MC, et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011, 34:703-709.
26. Thomas MC, Moran J, Forsblom C, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011, 34:861-866.
27. Holtkamp FA, de Zeeuw D, Thomas MC, et al. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int 2011, 80:282-287.
28. Apperloo AJ, de Zeeuw D, de Jong PE A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 1997, 51:793-797.
29. Vallon V, Huang DY, Deng A, Richter K, Blantz RC, Thomson S Salt-sensitivity of proximal reabsorption alters macula densa salt and explains the paradoxical effect of dietary salt on glomerular filtration rate in diabetes mellitus. J Am Soc Nephrol 2002, 13:1865-1871.
30. Vallon V, Wead LM, Blantz RC Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. J Am Soc Nephrol 1995, 5:1761-1767.
31. Luik PT, Hoogenberg K, van der Kleij FG, et al. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus. Diabetologia 2002, 45:535-541.